Harnessing the immunogenic function of dendritic cells to build vaccines and immunotherapies

We are currently exploring new technological avenues:

1°) To develop cancer immunotherapies mobilizing dendritic cells within solid tumors to boost the induction of adaptive immunity against tumor-associated antigens locally.

2°) To build new dendritic cell-targeted vaccines by delivering tumor-associated and viral antigens to memory-forming and memory-boosting dendritic cells.